Introduction
============

Age-related macular degeneration (AMD) is one of the major causes of visual impairments and blindness in developed regions [@B1]. Choroidal neovascularization (CNV) is a severe complication of the neovascular or wet AMD [@B2]. It is well known that vascular endothelial growth factor (VEGF) plays key roles in the pathogenesis of neovascular AMD [@B3], [@B4]. Numerous studies have demonstrated that anti-VEGF therapy is effective and safe for patients with CNV due to AMD for which it has been widely used in clinics [@B5], [@B6]. However, recent studies suggest that some VEGF neutralizing proteins are not effective in some patients [@B7], [@B8]. There is increasing evidence that a number of factors may be responsible for non-responses including tolerance or tachyphylaxis (a term refers to the sudden decrease in response to a drug after its administration) of anti-VEGF therapies [@B9], [@B10]. Therefore, there is an urgent need for the mechanistic understanding of CNV, to explore novel therapeutic targets for early intervention of CNV, which would provide potential alternatives to anti-VEGF therapies.

Long non-coding RNAs (lncRNAs) is a subtype of non-coding RNAs with the transcripts of more than 200 nucleotides [@B11]. Although lncRNAs have no protein-coding capacity, they may regulate physiological functions as well as pathological processes in many diseases [@B12]-[@B15]. In particular, the activation of lncRNAs might regulate the expression of protein-coding genes through sophisticated mechanisms in ocular disorders [@B16]-[@B19]. It has been reported that lncRNAs have differential expression profiles in a mouse model of ischemia-induced retinal neovascularization[@B20]. The role of lncRNAs in AMD has also been investigated in a number of studies. A study showed that lncRNAs are differentially expressed in RPE/choroid samples in patients with early AMD compared to controls and might be involved in important regulative functions [@B21]. Among altered lncRNAs in patients with early AMD, RP11-234O6.2 has been demonstrated as having protective effects in the aging RPE model [@B21]. A few *in vitro* studies investigated the roles of several certain lncRNAs (such as ZNF503-AS1 and BANCR) in retinal pigment epithelium (RPE) cells [@B22], [@B23]. Nevertheless, it still remains unclear that the expression profiles, targets, and effects of lncRNAs and their contribution to the pathogenesis of CNV as well as neovascular AMD.

Laser-induced CNV is a well-established mouse model to investigate the pathogenesis of CNV and neovascular AMD [@B24]. Previous studies using the CNV mouse model to examine the role of VEGF and many other molecules [@B25]-[@B27]. We recently identified altered microRNAs and tRNA-derived small RNAs in the laser-induced CNV model [@B28].

In the present study, microarray analyses were applied to clarify the expression profiles of lncRNAs and mRNAs in the CNV mouse model. In addition, bioinformatics analyses, including gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, were conducted to explore the related biological functions and potential signaling pathways of altered genes. Moreover, a coding-non-coding gene co-expression (CNC) network was established to investigate the correlation of differentially expressed lncRNAs and mRNAs, and to further predict the possible roles of differentially expressed lncRNAs in CNV.

Materials and Methods
=====================

Animals
-------

C57BL/6J mice (male, aged 7-8 weeks old) (SJA Laboratory Animal Co., Ltd., Hunan, China) were used for experiments in accordance to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The procedures were proved by the Institutional Animal Care and Use Committee of Central South University.

Laser-induced CNV mouse model
-----------------------------

As previously described, the CNV mouse model was induced by laser photocoagulation [@B27]-[@B29] with some modification. In brief, the photocoagulation was performed with 25 spots in each eye using a 532-nm diode laser (100 mW, 0.1 s duration, 50 μm). On day 7 after laser photocoagulation treatment, the eyes were enucleated. Age-matched C57BL/6J mice without the treatment were used as controls.

LncRNA and mRNA microarray analysis
-----------------------------------

Tissues of RPE-choroid-sclera complexes were collected from 4 eyes to be pooled as one sample, and a total of 6 samples (3 CNV samples and 3 control samples) were analyzed. Total RNA was isolated by using Trizol RNA extraction kit (Invitrogen, Carlsbad, CA, USA). The microarray analysis was performed by mouse lncRNA Microarray V3.0 (Arraystar, Rockville, MD, USA) as described [@B20]. The raw data of microarray has been uploaded to the Gene Expression Omnibus database (<http://www.ncbi.nlm.nih.gov/geo/>) for public access with the accession number GSE129743. Altered lncRNAs and mRNAs expression were identified by a Volcano Plot filtering \[fold change (FC) ≥1.5\] and P\<0.05.

Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR)
--------------------------------------------------------------------------------

The validation of lncRNA and mRNA microarray results was further processed by qRT-PCR [@B30]. RNA was transcribed into cDNA utilizing SuperScript Ⅲ Reverse Transcriptase (Invitrogen) following instructions of the manufacturer by Gene Amp PCR System 9700 (Applied Biosystems, Foster City, CA, USA). The qRT-PCR was performed by the ViiA 7 RT PCR System (Applied Biosystems) with the 2 × PCR Master Mix (Arraystar). LncRNAs\' relative expression levels were normalized with GAPDH [@B31], [@B32]. Primer used for qRT-PCR are shown in Table [1](#T1){ref-type="table"}. P\<0.05 was considered statistically significant differences.

GO and KEGG pathway analyses
----------------------------

GO analysis (<http://www.geneontology.org/>) and KEGG pathway analysis (<http://www.genome.jp/kegg/>) were used to investigate the potential biological functions and significant pathways of the altered mRNAs or CNC-associated mRNAs.

Construction of lncRNA-mRNA co-expression network
-------------------------------------------------

According to validated altered lncRNAs and their related mRNAs, we established a CNC network profile to explore the relationship between lncRNAs and mRNAs. We selected Pearson correlation coefficients (PCCs)≥ 0.97 to construct the network utilizing Cytoscape version 2.8.1 software (The Cytoscape Consortium, San Diego, CA, USA) based on the PCCs of correlation analysis of lncRNA and mRNA.

Results
=======

Expression profiles of lncRNA and mRNA in CNV mice
--------------------------------------------------

To assess the expressions of lncRNAs in CNV compared to control mice, microarray analysis was conducted in the collected RPE-choroid-sclera complexes. Our results showed that 716 lncRNAs were significantly altered in CNV mice compared to control mice: 442 were upregulated and 274 were downregulated (FC≥1.5, P\<0.05). The top 20 up- and downregulated lncRNAs are listed in Table [2](#T2){ref-type="table"}-[3](#T3){ref-type="table"}. Among the differentially expressed lncRNA transcripts, AK036888 tops among upregulated lncRNAs with an FC of 13.38, whereas ENSMUST00000135495 tops among downregulated lncRNAs with an FC of 7.47. The clustering analysis demonstrated the relevance of lncRNA expression patterns in CNV and control samples by showing the top 20 up- and downregulated lncRNAs (Fig. [1](#F1){ref-type="fig"}A). The variation of lncRNA expression between CNV and control mice is shown in a volcano plot (Fig. [1](#F1){ref-type="fig"}C) and a scatter plot (Fig. [1](#F1){ref-type="fig"}E).

We also identified that 821 mRNAs were significantly altered in CNV mice compared to control mice: 588 were upregulated and 233 were downregulated (FC≥1.5 , P\<0.05). The top 20 significantly altered mRNA are shown in Table [4](#T4){ref-type="table"}-[5](#T5){ref-type="table"}. Among those upregulated mRNAs, Aplnr (NM_011784) tops with an FC of 11.11, while expression of Prpmp5 (NM_001024705) tops among downregulated genes with FC of 3.61. The heatmap plot revealed the clustering analysis among mRNA expression patterns by presenting the top 20 up- and downregulated mRNAs in the collected samples (Fig. [1](#F1){ref-type="fig"}B). A volcano plot (Fig. [1](#F1){ref-type="fig"}D) and a scatter plot (Fig. [1](#F1){ref-type="fig"}F) showed the variation of mRNA expression between CNV and control mice.

Validation of the microarray data of lncRNAs by qRT-PCR
-------------------------------------------------------

To validate the accuracy and reliability of the microarray profiling data, seven lncRNAs (uc009ewo.1, AK148935, uc029sdr.1, ENSMUST00000132340, AK030988, uc007mds.1, ENSMUST00000180519) were randomly selected for qRT-PCR. The qRT-PCR results are consistent with the microarray analyses where expression of lncRNAs AK148935, ENSMUST00000132340, uc009ewo.1 and uc029sdr.1 were significantly upregulated and expression of lncRNAs AK030988, ENSMUST00000180519 and uc007mds.1 were significantly downregulated in CNV mice compared to control mice (Fig. [1](#F1){ref-type="fig"}G).

GO and KEGG pathway analyses of altered genes
---------------------------------------------

GO analyses of the 821 altered mRNAs showed that upregulated genes were enriched in immune system process (ontology: biological process, GO: 0002376), extracellular region (ontology: cellular component, GO: 0005576) and protein binding (ontology: molecular function, GO: 0005515) (Fig. [2](#F2){ref-type="fig"}A); while downregulated genes were enriched in anion transport (ontology: biological process, GO:0006820), plasma membrane region (ontology: cellular component, GO: 0098590) and secondary active transmembrane transporter activity (ontology: molecular function, GO: 0015291) (Fig. [2](#F2){ref-type="fig"}B).

KEGG pathway analysis of those differentially expressed mRNAs found that the upregulated genes were enriched in chemokine signaling pathway, cytokine-cytokine receptor interaction and *staphylococcus aureus* infection (Fig. [2](#F2){ref-type="fig"}C), while the downregulated genes were enriched in GABAergic synapse, Hippo signaling pathway and phototransduction (Fig. [2](#F2){ref-type="fig"}D).

CNC networks with GO and KEGG analyses
--------------------------------------

LncRNA and mRNA co-expression network was established based on 7 validated altered lncRNAs as well as 282 interacted mRNAs which were differentially expressed. The CNC network was composed of 289 nodes and 713 edges. There were 512 positive and 201 negative interactions within the network (Fig. [3](#F3){ref-type="fig"}). The lncRNA uc009ewo.1 is correlated with 138 mRNAs, ENSMUST00000132340 is correlated with 132 mRNAs, uc029sdr.1 is correlated with 152 mRNAs, ENSMUST00000180519 is correlated with 127 mRNAs, AK148935 is correlated with 76 mRNAs, while uc007mds.1 and AK030988 are correlated with 49 and 39 mRNAs respectively. According to the networks, the most relevant mRNAs are B430306N03Rik, C-type lectin receptor 4e (Clec4e) and paired immunoglobulin-like receptor A6 (Pira6), all correlated with 6 lncRNAs. To predict the functions of the lncRNAs, GO analyses and KEGG pathway analyses of those interacted mRNAs which were differentially expressed were conducted based on the results of the co-expression network. GO analysis showed that the most enriched GO terms of the targeted genes were immune system process (ontology: biological process, GO: 0002376), plasma membrane (ontology: cellular component, GO: 0005886) and protein binding (ontology: molecular function, GO: 0005515) (Fig. [4](#F4){ref-type="fig"}A). KEGG pathway analysis showed those targeted mRNAs were enriched in chemokine signaling pathway, osteoclast differentiation and cytokine-cytokine receptor interaction (Fig. [4](#F4){ref-type="fig"}B).

Discussion
==========

Despite several studies reported important roles of particular lncRNAs such as ZNF503-AS1 and BANCR in RPE cells through *in vitro* studies [@B22], [@B23], none of them have investigated the role of lncRNAs in CNV. The present study profiled lncRNA and mRNA expression in the mouse model of laser-induced CNV by integrated microarray analysis. We identified 821 significantly altered mRNAs (588 upregulated; 233 downregulated) and 716 differentially expressed lncRNAs (442 upregulated; 274 downregulated) in the RPE-choroid-sclera complexes from CNV mice compared to control mice. Validation of seven randomly chosen lncRNAs by qRT-PCR further confirmed the reliability of microarray analysis. The profiles of the lncRNAs and mRNAs in CNV mice provide novel insights into our understanding of the pathogenesis of CNV.

A number of studies have reported that different cytokines, such as IL-10, IL-12, IFN-γ, IL-17, IL-18 and IL-33, may play a role in the pathogenesis of CNV [@B33]-[@B37]. The pro- and anti-angiogenic effects of the cytokines relevant to Th1, Th2 and Th17 cells, participate in a complicated immunological network [@B38]. It has been reported that the number of macrophages increased significantly after laser photocoagulation [@B24], and M1-M2 polarization of macrophages have diverse distributions and functions in laser-induced CNV as well as in wet AMD [@B39]-[@B41]. Pro-inflammatory M1 macrophages increased in the site of CNVs [@B39], suggesting that inflammation might play a key role in the pathogenesis of CNV and AMD. Our GO analyses showed that the most upregulated genes participate in immune system process, whereas the downregulated genes participate in plasma membrane region. Moreover, the KEGG pathway analysis revealed that the functions of altered genes are enriched in the chemokine signaling pathway, cytokine-cytokine receptor interaction and the GABAergic synapse. Similarly, GO and KEGG pathway analyses of the lncRNA-interacted mRNAs showed that the most enriched GO terms are associated with immune system process and immune response, and the most enriched KEGG pathway is also chemokine signaling pathway. These analyses demonstrated that CNV might be mainly immune-regulated by cytokines and chemokines.

Macrophage inducible Ca2+-dependent lectin receptor (Mincle) is a member of the C-type lectin family of immune receptors, which encoded by the gene of Clec4e, and Clec4e is also a type 2 transmembrane receptor [@B42]. As the CNC network analysis showed, Clec4e is a significantly altered gene correlated with 6 validated lncRNAs. *Lv et al.* reported that clec4e is induced specifically on M1 macrophages, and it plays an essential role in maintaining the phenotype of M1 macrophage in acute renal inflammation [@B43]. Another study showed that that Clec4e enhanced proinflammatory phenotype of macrophages through activation of the unfolded protein response [@B44]. Our previous study demonstrated that M1 macrophages mainly distribute around the site of CNVs, and inflammatory M1 macrophage-associated cytokines increased in RPE and choroid in laser-induced CNV mouse model [@B39]. Thus Clec4e, as well as macrophage polarization are possibly involved in mRNA-lncRNA network.

Nevertheless, the relevance of lncRNAs and cytokines or macrophages in intraocular neovascularization is still unclear. Our GO analysis suggested that several altered lncRNAs are involved in the regulation of cytokines and immunological networks in the pathogenesis of CNV, however, further studies should be guaranteed to investigate the exact functions and mechanisms of the dysregulated lncRNAs. Chemokines are a group of small chemoattractant cytokines, which play great roles in inflammation and regulating angiogenesis as well as macrophage polarization [@B45], [@B46]. Studies have shown that chemokine (C-X-C motif) ligand 8 (CXCL8) and monocyte chemoattractant protein-1 (MCP-1), and chemokine receptors such as CXC chemokine receptor 3 (CXCR3) have been reported to be involved in CNV and AMD pathogenesis [@B47], [@B48]. A study showed that miR-539-5p attenuates experimental CNV through targeting CXC chemokine receptor 7 (CXCL7) [@B49], indicating that non-coding RNAs are involved in the functional effect of chemokines and their receptors that contribute to the formation of CNV. In the present study, GO and KEGG analyses showed that altered genes enriched in immune system process, immune response, chemokine signaling pathway and cytokine-cytokine receptor interaction, indicating that lncRNAs may regulate chemokines, cytokines and their receptors in the pathogenesis of CNV formation through their target genes. Thus, it is worth further investigate the mechanisms of involvement of lncRNAs in chemokines and chemokine receptors in CNV and AMD.

*Zhu et al.* presented identified lncRNAs involved in early AMD [@B21]. In that study, GO and KEGG analyses showed that lncRNA-related genes enriched different functions, such as visual perception, sensory perception of light stimuli, and phototransduction pathway, but not immunological regulations. It might because that study focused on early-stage AMD patients without geographic atrophy and CNV, and our present study investigated the pathogenesis of CNV, which demonstrated different roles of lncRNAs in AMD.

We recently demonstrated that both mRNAs and lncRNAs have differential expression profiles in the oxygen-induced retinopathy (OIR) mouse model [@B20], which is used for investigation of retinal neovascular diseases. We recognized 539 altered mRNAs and 373 altered lncRNAs in OIR retinas (FC≥2.0, P\<0.05) [@B20]. And we tried to check the intersection of altered RNAs in both models, and identified 161 mRNAs and 53 lncRNAs which altered in OIR as well as CNV models, and the majority of the RNAs have the same trend of alteration. For instance, ENSMUST00000165968 and CD68 were up-regulated in both models, while ENSMUST00000144657 and cpa2 were down-regulated in both models. These double-dysregulated mRNAs and lncRNAs might play more essential roles in angiogenesis, and this suggested that lncRNAs could have potential roles in the pathogenesis of ocular neovascular diseases.

In conclusion, the present study reveals that lncRNAs and mRNAs are significantly altered in CNV mice through microarray analysis. Further, GO and pathway analyses indicate that altered lncRNAs are not only involved in biological processes of immune mechanisms and inflammation but also are involved in the related pathways which might contribute to CNV and AMD pathogenesis. In particular, immunological networks, including cytokines, chemokines and their receptors are mainly involved and relevant to the effect of lncRNAs in CNV. The limitation of this study is the lack of functional assessment of the identified lncRNA and mRNAs. Therefore, further studies are required to investigate the potential roles and exact mechanisms of the altered lncRNAs and mRNAs in CNV.
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![**Altered expressions of lncRNAs and mRNAs between CNV group and control group by microarray.** Heat map and hierarchical clustering analysis of the top 20 up- and downregulated lncRNAs (A) and mRNAs (B) between CNV and control samples. The top column represents lncRNA and mRNA relative expression varies according to the color scale. The volcano plot presents all identified lncRNA (C) and mRNA (D) expression variation between the CNV and control samples. The horizontal green line shows the default 1.5-fold change and the vertical green line represents a P-value of 0.05. The red and green plots represent up- and downregulated RNAs with FC≥1.5 and P\<0.05. The scatter plot presents all identified lncRNA (E) and mRNA (F) expression variation between the CNV and control samples. The x-axis and y-axis values are each sample\'s normalized values (log2 transformed). The gray line shows the default 1.5-fold changes. The red and green plots represent altered RNAs with FC≥1.5. The qRT-PCR validation of seven randomly selected lncRNAs: AK148935, ENSMUST00000132340, uc009ewo.1, uc029sdr.1, AK030988, ENSMUST00000180519, uc007mds.1 (G).](ijmsv17p0292g001){#F1}

![**The GO and KEGG analyses of altered mRNAs.** The GO analyses of up- (A) and downregulated (B) mRNAs. KEGG pathway analysis of altered mRNAs indicated: the top 10 significant enriched pathways of the upregulated genes (C), and the top 5 significant enriched pathways of the downregulated genes (D).](ijmsv17p0292g002){#F2}

![**CNC networks by validated lncRNAs.** The co-expression network profiles of lncRNAs and mRNAs based on 7 validated lncRNAs and correlated mRNAs which were differentially expressed. This co-expression network composed of 713 edges and 289 nodes. The diamond nodes represent lncRNAs, in which yellow denotes upregulated lncRNAs and blue denotes downregulated lncRNAs. The round nodes represent mRNAs, in which green denotes upregulated mRNAs and red denotes downregulated mRNAs. Continuous and dotted lines indicate positive and negative interactions between lncRNAs and mRNAs, respectively.](ijmsv17p0292g003){#F3}

![**The GO and KEGG analyses of interacted and altered mRNAs in CNC networks.** GO analysis of the CNC-associated altered mRNAs (A). KEGG pathway analysis of the CNC-associated altered mRNAs (B).](ijmsv17p0292g004){#F4}

###### 

Sequence of the primers for lncRNAs.

  ----------------------------------------------------------------------------------------
                       Forward and reverse primer           Tm (℃)   Product length (bp)
  -------------------- ------------------------------------ -------- ---------------------
  GAPDH (MOUSE)        F:5\' CACTGAGCAAGAGAGGCCCTAT3\'\     60       144
                       R:5\' GCAGCGAACTTTATTGATGGTATT3\'             

  uc009ewo.1           F:5\' GGTAAGTCCCCACTATCATTCTC 3\'\   60       184
                       R:5\' AAACACCTTTGCCCTCCTC 3\'                 

  AK148935             F:5\' TTTGTTGGCTGCCTTCTTTC 3\'\      60       72
                       R:5\' TGACTAACCTGTGAGTGTCCCTA 3\'             

  uc029sdr.1           F:5\' CTCTTGATGTATCCCAGGGTG 3\'\     60       210
                       R:5\' CAGGAAACACAATGCTACTCTC 3\'              

  ENSMUST00000132340   F:5\' CGGAATGTTACTGCCCATAG 3\'\      60       254
                       R:5\' TGGTCATTAGGATAAGTTCTGG 3\'              

  AK030988             F:5\' TGGGACCTAAGGATGGAAGA 3\'\      60       167
                       R:5\' AGACCAGAGCCAATGTGAGC 3\'                

  uc007mds.1           F:5\' TTCAGCCCCGACGAGCAC 3\'\        60       187
                       R:5\' GAAAGGGTTTGTTCGGCTCAC 3\'               

  ENSMUST00000180519   F:5\' TCTGGTTCTCGGCTATGTGC 3\'\      60       129
                       R:5\' AACAACAGCACAAACAGGGT 3\'                
  ----------------------------------------------------------------------------------------

Tm: temperature. bp: base pair.

###### 

Top 20 significantly up-regulated lncRNAs.

  Sequence Name        P-value    FDR        Fold Change   Regulation   Strand   Relationship               CNV 1       CNV 2       CNV 3       Control 1   Control 2   Control 3
  -------------------- ---------- ---------- ------------- ------------ -------- -------------------------- ----------- ----------- ----------- ----------- ----------- -----------
  AK036888             0.000171   0.150561   13.378940     up           \-       intergenic                 6.585418    6.480785    6.071276    3.077727    2.512265    2.321811
  uc007pgi.1           0.014847   0.390976   9.578848      up           \-       intergenic                 5.211190    7.107776    4.430212    2.325983    2.321827    2.321811
  AK078702             0.000536   0.150561   7.117427      up           \-       intergenic                 6.359641    6.132188    6.161450    3.862077    3.371296    2.925838
  AK035526             0.005083   0.298875   6.657825      up           \+       natural antisense          5.724644    7.089529    7.076339    4.231499    3.878298    3.575563
  uc009ewo.1           0.000984   0.182037   5.719433      up           \-       intron sense-overlapping   8.163315    7.829017    7.371524    5.300458    5.566779    4.949003
  AK036625             0.005126   0.298875   5.353162      up           \-       intergenic                 5.726749    5.680111    5.143081    2.325983    3.345529    3.617254
  ENSMUST00000148005   0.001561   0.218932   5.264145      up           \+       exon sense-overlapping     6.509248    6.302205    5.601678    3.998450    3.479648    3.746437
  ENSMUST00000153541   0.000164   0.150561   4.957192      up           \+       exon sense-overlapping     11.456490   11.349358   10.999685   9.005207    9.098501    8.773256
  AK008836             0.004393   0.293747   4.888444      up           \-       intronic antisense         7.371524    6.772026    6.602773    4.573347    5.202004    4.102845
  ENSMUST00000146254   0.000028   0.106609   4.640225      up           \-       exon sense-overlapping     7.526886    7.218386    7.363228    5.129217    5.254380    5.082319
  NR_026843            0.001265   0.203615   4.591574      up           \-       natural antisense          6.264922    6.398417    5.991045    4.478630    3.930072    3.648715
  ENSMUST00000122340   0.001105   0.191468   4.442445      up           \-       intronic antisense         8.984519    8.526921    8.527271    6.376287    6.936308    6.272055
  AK082144             0.000016   0.106609   4.424734      up           \-       intergenic                 6.554079    6.639836    6.746826    4.380675    4.513834    4.609461
  AK048117             0.001609   0.221747   4.382340      up           \-       intergenic                 9.343423    9.431755    9.431267    7.627238    6.720520    7.463583
  ENSMUST00000143423   0.000941   0.181475   4.307678      up           \+       exon sense-overlapping     4.561347    5.009892    4.564078    2.963872    2.321827    2.528887
  AK148935             0.000638   0.156222   4.263167      up           \-       intergenic                 8.259856    8.525405    8.333067    6.682964    6.086507    6.073080
  AK047865             0.001065   0.191468   4.256438      up           \-       intergenic                 9.039629    8.963352    9.098866    7.275191    6.469285    7.088430
  ENSMUST00000141975   0.000283   0.150561   4.232972      up           \-       exon sense-overlapping     6.736901    6.384502    6.153523    4.416513    4.338800    4.274602
  uc029sdr.1           0.000052   0.120829   4.185189      up           \+       intergenic                 10.768113   10.641598   10.589025   8.507404    8.798939    8.496515
  NR_045384            0.010196   0.362008   4.172997      up           \+       intergenic                 5.724329    5.884554    5.893274    4.532355    3.801238    2.985313

P-values were calculated using unpaired t-test. FDR: false discovery rate. Fold change: the absolute ratio (no log scale) of average normalized intensities between CNV group and control group. CNV 1 to 3 and Control 1 to 3: each sample\'s normalized intensity (log2 scale). Hereinafter the same.

###### 

Top 20 significantly down-regulated lncRNAs.

  Sequence Name        P-value    FDR        Fold Change   Regulation   Strand   Relationship             CNV1       CNV2       CNV3       Control1   Control2   Control3
  -------------------- ---------- ---------- ------------- ------------ -------- ------------------------ ---------- ---------- ---------- ---------- ---------- ----------
  ENSMUST00000135495   0.044869   0.516189   7.465422      down         \-       exon sense-overlapping   4.264994   6.259270   3.847529   8.927113   6.595256   7.550095
  ENSMUST00000151832   0.042431   0.506906   3.682991      down         \+       exon sense-overlapping   3.973213   5.239059   4.472576   5.519285   6.476424   7.331772
  AK079094             0.000472   0.150561   2.875171      down         \-       natural antisense        4.097720   3.991172   3.967711   5.716774   5.645347   5.265424
  ENSMUST00000171338   0.003991   0.284707   2.831007      down         \-       exon sense-overlapping   4.347292   4.591844   4.052868   6.017756   5.435850   6.042344
  ENSMUST00000147716   0.002243   0.244886   2.805529      down         \-       intergenic               7.029440   6.772935   7.329016   8.414517   8.813207   8.368486
  AK030988             0.004724   0.293747   2.720887      down         \-       intergenic               7.828629   8.353325   8.177764   9.318910   9.964228   9.408810
  ENSMUST00000148202   0.005363   0.303718   2.572706      down         \-       intergenic               3.028002   2.478576   3.041757   3.901149   4.463217   4.273829
  AK005624             0.012396   0.380110   2.559854      down         \+       bidirectional            4.166821   3.256077   3.443728   5.159213   5.085467   4.690131
  AK009740             0.014086   0.383884   2.485166      down         \-       bidirectional            2.530040   3.314212   2.545198   4.152919   4.397770   3.778787
  ENSMUST00000155217   0.000964   0.182037   2.460863      down         \-       intronic antisense       7.949919   8.236430   8.067902   9.477743   9.536148   9.137853
  NR_037995            0.007062   0.335485   2.453643      down         \-       bidirectional            7.028992   6.600705   6.301580   8.136388   8.017734   7.661932
  ENSMUST00000155625   0.004510   0.293747   2.406930      down         \-       exon sense-overlapping   2.323709   2.787010   2.712476   4.039022   4.044215   3.541541
  uc007lit.1           0.039689   0.498925   2.389210      down         \+       natural antisense        3.383898   2.440709   2.323922   3.760049   4.469326   3.688754
  ENSMUST00000141135   0.027081   0.445563   2.334129      down         \+       exon sense-overlapping   3.241041   2.759476   2.558381   3.748812   3.811546   4.667192
  NR_033584            0.001977   0.240414   2.331771      down         \+       intergenic               4.933888   5.203815   5.150325   6.451165   6.479938   6.021205
  TCONS_00016118       0.007575   0.340233   2.312752      down         \-       intronic antisense       5.561865   5.562532   4.940521   6.790447   6.549662   6.353641
  AK029573             0.013265   0.380110   2.305416      down         \+       natural antisense        4.500548   3.852448   3.562495   5.301173   5.106782   5.122617
  ENSMUST00000144044   0.040861   0.503207   2.225878      down         \+       exon sense-overlapping   4.548734   5.325275   4.294675   6.335644   5.575793   5.720369
  NR_033469            0.005124   0.298875   2.225231      down         \+       intergenic               6.507724   6.533446   6.704603   7.941327   7.926619   7.339692
  AK013439             0.011666   0.378564   2.208164      down         \+       intergenic               6.454914   6.874332   6.432539   7.343084   8.090536   7.756705

###### 

Top 20 significantly up-regulated mRNAs.

  Sequence Name   Gene Symbol   P-value    Fold Change   Regulation   Chrom   CNV 1       CNV 2       CNV 3       Control 1   Control 2   Control 3
  --------------- ------------- ---------- ------------- ------------ ------- ----------- ----------- ----------- ----------- ----------- -----------
  NM_011784       Aplnr         0.000012   11.110603     up           chr2    7.033988    6.843315    7.167412    3.528313    3.702581    3.392226
  NM_011646       Try4          0.001518   10.794919     up           chr6    5.868813    6.207469    6.427937    3.563739    2.321827    2.321811
  NM_008372       Il7r          0.000099   9.886701      up           chr15   6.023879    5.297020    5.565189    2.325983    2.321827    2.321811
  NM_177843       Gm14461       0.001185   8.779374      up           chr2    7.331272    7.067940    6.677774    3.347988    4.486817    3.839826
  NM_001003405    Try5          0.000012   8.310638      up           chr6    5.221975    5.431142    5.596919    2.325983    2.437364    2.321811
  NM_206535       Cd200r2       0.000381   7.767570      up           chr16   6.312686    6.182743    5.670891    2.734021    3.294071    3.265839
  NM_175406       Atp6v0d2      0.001067   7.672187      up           chr4    10.914325   10.474780   10.348221   7.376840    8.241582    7.299991
  NM_011089       Pira2         0.000091   7.671351      up           chr7    6.094800    5.933179    5.760588    2.792479    3.300848    2.876798
  NM_207244       Cd200r4       0.006075   7.548943      up           chr16   6.464434    6.282340    5.594127    2.325983    3.989506    3.276587
  NM_008311       Htr2b         0.000706   7.192641      up           chr1    10.557041   10.345577   9.884406    7.819662    7.395292    7.032505
  NM_011088       Pira11        0.000196   6.976422      up           chr7    10.466558   10.217773   10.155017   7.762837    7.555972    7.113078
  NM_011094       Pira7         0.000161   6.963833      up           chr7    10.961688   10.969189   10.845609   8.455120    8.155355    7.766367
  NM_028973       Lrrc15        0.012774   6.827810      up           chr16   8.322155    8.931940    10.139378   6.901063    6.511550    5.666592
  NM_178241       Cxcr1         0.003685   6.805119      up           chr1    6.005635    5.869263    5.788451    3.879585    2.321827    3.162076
  NM_001166672    Gm14548       0.000097   6.673624      up           chr7    11.580840   11.296632   11.179657   8.847641    8.587764    8.406313
  NM_019948       Clec4e        0.000563   6.596644      up           chr6    5.670682    5.027602    5.075513    2.887439    2.399350    2.321811
  NM_011087       Pira1         0.003576   6.187779      up           chr7    5.488713    5.426346    5.204069    2.325983    3.583068    2.321811
  NM_001267695    Ctss          0.000957   5.934620      up           chr3    9.404564    8.806512    8.751737    6.192754    6.833984    6.228608
  NM_008848       Pira6         0.000255   4.851621      up           chr7    4.801415    4.635361    4.962917    2.325983    2.838959    2.399350
  NM_008404       Itgb2         0.001909   4.841209      up           chr10   9.670052    8.907650    8.869934    6.768681    7.213496    6.639358

###### 

Top 20 significantly down-regulated mRNAs.

  Sequence Name   Gene Symbol   P-value    Fold Change   Regulation   Chrom   CNV 1       CNV 2       CNV 3       Control 1   Control 2   Control 3
  --------------- ------------- ---------- ------------- ------------ ------- ----------- ----------- ----------- ----------- ----------- -----------
  NM_001024705    Prpmp5        0.014868   3.605863      down         chr6    9.067530    8.986222    9.954781    11.192267   11.751723   10.615577
  NM_019840       Pde4b         0.001704   2.927001      down         chr4    3.256077    3.624609    3.076331    5.079052    4.632161    4.894074
  NM_175296       Mael          0.013959   2.785800      down         chr1    5.162247    5.565056    5.125866    7.062294    7.111513    6.113637
  NM_008623       Mpz           0.008683   2.769509      down         chr1    12.174806   13.137897   12.638795   13.881432   14.154913   14.324043
  NM_183160       Tmem252       0.006698   2.677545      down         chr19   3.883402    4.178289    4.299822    5.111757    5.964037    5.548451
  NM_207280       Ccdc121       0.014313   2.450424      down         chr1    2.805933    2.324675    2.323922    3.639443    3.399682    4.294497
  NM_001025255    Mbp           0.000151   2.427744      down         chr18   2.949733    3.182399    3.054139    4.463824    4.263468    4.297829
  NM_026925       Pnlip         0.028181   2.426672      down         chr19   3.116513    2.324675    2.323922    3.895614    3.380287    4.326145
  NM_001113373    Shank2        0.023401   2.379186      down         chr7    3.648482    3.438832    2.672217    4.131874    4.666463    4.712598
  NM_001081153    Unc13c        0.034934   2.372052      down         chr9    11.000760   10.198641   11.528724   12.222275   12.268342   11.975915
  NM_001122594    Phlpp2        0.001196   2.356591      down         chr8    3.131635    2.660591    2.931842    4.163803    4.026565    4.243805
  NM_001161722    Tfeb          0.003061   2.335554      down         chr17   2.690098    3.230295    2.904800    4.046248    4.066880    4.383359
  NM_028807       Exoc3l4       0.026008   2.331869      down         chr12   4.272006    3.720309    3.146549    5.178742    4.693262    4.931320
  NM_001127685    BC048943      0.013403   2.324064      down         chr12   9.447387    8.766418    8.507593    10.125555   10.236406   10.009386
  NM_001204253    Clec1b        0.008321   2.321635      down         chr6    4.644223    5.290836    4.979474    5.859919    6.408708    6.291329
  NM_007545       Hrk           0.003712   2.290870      down         chr5    7.678339    8.078760    7.425854    8.965889    8.983374    8.821377
  NM_010220       Fkbp5         0.029949   2.281321      down         chr17   6.708265    6.429901    7.553089    8.247108    8.176554    7.837201
  NM_020599       Rlbp1         0.007127   2.235286      down         chr7    8.194874    8.097004    7.941646    9.260371    9.602041    8.852490
  NM_147110       Olfr570       0.003044   2.223418      down         chr7    5.491363    5.307785    5.178571    6.613100    6.653939    6.169017
  NM_027790       Dhrs2         0.003418   2.203722      down         chr14   5.776111    6.199949    5.806094    6.968227    7.311111    6.922644
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